Smart 'Poop' device could revolutionize constipation care

NCT ID NCT04903470

Recruiting now Knowledge-focused Sponsor: The California Medical Innovations Institute, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new device called Fecobionics, which looks and feels like a normal stool, to better understand how people with chronic constipation defecate. Researchers will measure pressures and movements in the rectum and anal canal in 130 healthy volunteers and constipated patients. They will also use drugs that speed up or slow down bowel movements to see how the device detects changes. The goal is to improve diagnosis and guide future treatments for constipation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Bisacodyl and Atropine
What this could lead to: If successful, this research could lead to better diagnostic tools and more effective treatments for chronic constipation.
What could go wrong: This is an early-stage observational study with only 130 participants, so results may not apply to everyone. The device is still experimental.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC CONSTIPATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

constipation disorder outlet dysfunction constipation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CONSTIPATION BY OUTLET OBSTRUCTION

Contacts and locations

Locations

Augusta University Medical Center
RECRUITING

Augusta, Georgia, 30912, United States
California Medical Innovations Institute
ACTIVE_NOT_RECRUITING

San Diego, California, 92121, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.